Advertisement
Advertisement
U.S. Markets close in 5 hrs 30 mins
Advertisement
Advertisement
Advertisement
Advertisement

Organovo Holdings, Inc. (ONVO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.7750-0.1250 (-4.31%)
As of 10:28AM EST. Market open.
Advertisement

Organovo Holdings, Inc.

440 Stevens Avenue
Suite 200
Solana Beach, CA 92075
United States
858 224 1000
https://www.organovo.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees11

Key Executives

NameTitlePayExercisedYear Born
Mr. Keith E. MurphyExec. Chairman & Principal Exec. Officer397.18kN/A1972
Dr. Jeffrey N. MinerChief Scientific Officer221.09kN/A1962
Mr. Thomas Einar Jurgensen J.D., MSGen. Counsel & Corp. Sec.264.86kN/A1957
Mr. Thomas P. Hess CPA, MBAPres & CFON/AN/A1964
Mr. Steve E. KunszaboVP of Investor Relations & Corp. CommunicationsN/AN/AN/A
Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds. It is also developing in vivo liver tissues to treat end-stage liver, life-threatening, and orphan diseases. The company was incorporated in 2007 and is headquartered in Solana Beach, California.

Corporate Governance

Organovo Holdings, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Advertisement
Advertisement